CLINICAL AND PHARMACOLOGICAL EVALUATION OF THE INFLUENCE OF DIFFERENT CLINICAL FACTORS ON THE DETERMINED LEVEL OF GLYCATED HEMOGLOBIN IN PATIENTS WITH DIABETES MELLITUS TYPE 2 (26-31)